Jennifer Da Silva

2.0k total citations · 1 hit paper
24 papers, 956 citations indexed

About

Jennifer Da Silva is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Jennifer Da Silva has authored 24 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 5 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Jennifer Da Silva's work include Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (8 papers) and Tracheal and airway disorders (7 papers). Jennifer Da Silva is often cited by papers focused on Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (8 papers) and Tracheal and airway disorders (7 papers). Jennifer Da Silva collaborates with scholars based in France, Brazil and Italy. Jennifer Da Silva's co-authors include Pierre‐Régis Burgel, Clémence Martin, I. Durieu, R. Chiron, Olivier Lantz, Agnès Lehuen, Jamie Rossjohn, Laurent Mély, Lydie Lemonnier and James McCluskey and has published in prestigious journals such as Nature Communications, Nature Immunology and PLoS ONE.

In The Last Decade

Jennifer Da Silva

21 papers receiving 949 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

2021 148 citations Pierre‐Régis Burgel, I. Durieu et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers

Countries citing papers authored by Jennifer Da Silva

Since Specialization

Citations

This map shows the geographic impact of Jennifer Da Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Da Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Da Silva more than expected).

Fields of papers citing papers by Jennifer Da Silva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Da Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Da Silva. The network helps show where Jennifer Da Silva may publish in the future.

Co-authorship network of co-authors of Jennifer Da Silva

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Da Silva. A scholar is included among the top collaborators of Jennifer Da Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Da Silva. Jennifer Da Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of structural predictors of lung function improvement in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor using deep-learning 2025 ·Diagnostic and Interventional Imaging ·Guillaume Chassagnon, (unknown), (unknown), Jennifer Da Silva, (unknown), Isabelle Honoré, Reem Kanaan, Nicolas Carlier, (unknown), Espérie Burnet, Marie‐Pierre Revel, Clémence Martin, Pierre‐Régis Burgel	0
2	Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice 2025 ·PLoS ONE ·Alexandra Cambier, Jennifer Da Silva, (unknown), (unknown), (unknown), Aurélie Sannier, (unknown), Erwan Boedec, (unknown), Renato C. Monteiro	0
3	Population Pharmacokinetics of Elexacaftor, Tezacaftor and Ivacaftor in a Real-World Cohort of Adults with Cystic Fibrosis 2025 ·Clinical Pharmacokinetics ·(unknown), Naïm Bouazza, Frantz Foissac, (unknown), Gabrielle Lui, Nicolas Carlier, Jennifer Da Silva, (unknown), Reem Kanaan, Isabelle Honoré, Clémence Martin, Jean‐Marc Tréluyer, Pierre‐Régis Burgel, Sihem Benaboud	0
4	Elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis harbouring two CFTR Class I variants: real-world data from the French compassionate programme 2025 ·EClinicalMedicine ·Pierre‐Régis Burgel, Emmanuelle Girodon, Neeraj Sharma, Caroline Raynal, Jennifer Da Silva, Souphatta Sasorith, Clémence Martin, Isabelle Sermet‐Gaudelus, Karen S. Raraigh	1
5	Reversal of cylindrical bronchial dilatations in a subset of adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor 2024 ·European Respiratory Journal ·(unknown), Guillaume Chassagnon, (unknown), Jennifer Da Silva, Reem Kanaan, Isabelle Honoré, Nicolas Carlier, Marie‐Pierre Revel, (unknown), Clémence Martin, Pierre‐Régis Burgel	10
6	Multisystemic Effects of Elexacaftor–Tezacaftor–Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease 2024 ·Annals of the American Thoracic Society ·Pierre‐Régis Burgel, Jean-Louis Paillasseur, I. Durieu, Martine Reynaud‐Gaubert, Rébecca Hamidfar, M. Murris‐Espin, Isabelle Danner‐Boucher, R. Chiron, Sylvie Leroy, Benoît Douvry, Dominique Grenet, Laurent Mély, Sophie Ramel, (unknown), Espérie Burnet, (unknown), Philippe Sogni, Jennifer Da Silva, Clémence Martin	18
7	MAIT cells altered phenotype and cytotoxicity in lupus patients are linked to renal disease severity and outcome 2023 ·Frontiers in Immunology ·Е. Г. Литвинова, (unknown), (unknown), Jennifer Da Silva, (unknown), Lucie Beaudoin, (unknown), (unknown), Agnès Lehuen, Éric Daugas, Renato C. Monteiro, Héloïse Flament	7
8	The French Compassionate Program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508delCFTRvariant 2023 ·European Respiratory Journal ·Pierre‐Régis Burgel, Isabelle Sermet‐Gaudelus, I. Durieu, Reem Kanaan, Julie Macey, Dominique Grenet, Michele Porzio, (unknown), R. Chiron, Christophe Marguet, Benoît Douvry, Nadine Dufeu, Isabelle Danner‐Boucher, P. Foucaud, Lydie Lemonnier, Emmanuelle Girodon, Jennifer Da Silva, Clémence Martin	42
9	Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations 2022 ·Frontiers in Immunology ·Clémence Martin, (unknown), Maha Zohra Ladjemi, Muriel Andrieu, (unknown), (unknown), Frédéric Pène, Jennifer Da Silva, Pierre‐Régis Burgel, Véronique Witko‐Sarsat	12
10	Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis 2022 ·Journal of Cystic Fibrosis ·Clémence Martin, Martine Reynaud‐Gaubert, Rébecca Hamidfar, I. Durieu, M. Murris‐Espin, Isabelle Danner‐Boucher, R. Chiron, Sylvie Leroy, Benoît Douvry, Dominique Grenet, Laurent Mély, Sophie Ramel, (unknown), Lydie Lemonnier, Espérie Burnet, Jean-Louis Paillasseur, Jennifer Da Silva, Pierre‐Régis Burgel	41
11	CFTR Modulators: Current Status and Evolving Knowledge 2022 ·Seminars in Respiratory and Critical Care Medicine ·Lucile Regard, Clémence Martin, Jennifer Da Silva, Pierre‐Régis Burgel	13
12	Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease breakdown → 2021 ·American Journal of Respiratory and Critical Care Medicine ·Pierre‐Régis Burgel, I. Durieu, R. Chiron, Sophie Ramel, Isabelle Danner‐Boucher, Anne Prévötat, Dominique Grenet, Christophe Marguet, Martine Reynaud‐Gaubert, Julie Macey, Laurent Mély, Annlyse Fanton, S. Quétant, Lydie Lemonnier, Jean-Louis Paillasseur, Jennifer Da Silva, Clémence Martin	148
13	Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy 2021 ·Kidney International ·Alexandra Cambier, Patrick J. Gleeson, Lilia Abbad, (unknown), Jennifer Da Silva, Julie Bex-Coudrat, Georges Deschênes, Olivia Boyer, Marion Rabant, Tim Ulinski, Julien Hogan, M. Peuchmaur, Laureline Berthelot, Renato C. Monteiro	21
14	Using chest CT scan and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis 2021 ·European Respiratory Journal ·(unknown), Enzo Battistella, Clémence Martin, I. Durieu, Laurent Mély, Christophe Marguet, C. Belleguic, M. Murris‐Espin, R. Chiron, Annlyse Fanton, S. Bui, Martine Reynaud‐Gaubert, Philippe Reix, Trieu-Nghi Hoang-Thi, Maria Vakalopoulou, Marie‐Pierre Revel, Jennifer Da Silva, Pierre‐Régis Burgel, Guillaume Chassagnon	25
15	Real-world assessment of LCI following lumacaftor-ivacaftor initiation in adolescents and adults with cystic fibrosis 2021 ·Journal of Cystic Fibrosis ·Philippe Reix, Aurélie Tatopoulos, Iulia Ioan, Muriel Le Bourgeois, S. Bui, (unknown), (unknown), M. Gérardin, Plamen Bokov, Jennifer Da Silva, Jean-Louis Paillasseur, Pierre‐Régis Burgel	8
16	Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity 2020 ·Nature Communications ·Amine Toubal, Badr Kiaf, Lucie Beaudoin, (unknown), Moez Rhimi, (unknown), Jennifer Da Silva, Alexandra J. Corbett, Yannick Simoni, Olivier Lantz, Jamie Rossjohn, James McCluskey, Philippe Lesnik, Emmanuelle Maguin, Agnès Lehuen	120
17	Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis 2019 ·American Journal of Respiratory and Critical Care Medicine ·Pierre‐Régis Burgel, À. Munck, I. Durieu, R. Chiron, Laurent Mély, Anne Prévötat, M. Murris‐Espin, Michele Porzio, Michel Abély, Philippe Reix, Christophe Marguet, Julie Macey, Isabelle Sermet‐Gaudelus, Harriet Corvol, S. Bui, Lydie Lemonnier, Clémence Dehillotte, Jennifer Da Silva, Jean-Louis Paillasseur, D. Hubert	92
18	Changes in the chemical composition and bioactive compounds of chickpea (Cicer arietinum L.) fortified by germination 2019 ·LWT ·Cristiano Dietrich Ferreira, (unknown), Jennifer Da Silva, (unknown), Valmor Ziegler, Chirle de Oliveira Raphaelli, Maurício de Oliveira	63
19	Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes 2017 ·Nature Immunology ·Ophélie Rouxel, Jennifer Da Silva, Lucie Beaudoin, Isabelle Nel, Céline Tard, (unknown), Badr Kiaf, Masaya Oshima, Marc Diedisheim, Marion Salou, Alexandra J. Corbett, Jamie Rossjohn, James McCluskey, Raphaël Scharfmann, Manuela Battaglia, Michel Polak, Olivier Lantz, Jacques Beltrand, Agnès Lehuen	184
20	Effects of the Roasting Process Over the Content of Secondary Metabolites from Peanut Grains (Arachis hypogaea. L) with Different Colorations of Testa 2016 ·Journal of Food Quality ·Cristiano Dietrich Ferreira, Valmor Ziegler, (unknown), Jennifer Da Silva, (unknown), M. C. Elias, Maurício de Oliveira	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact